Vol 12, No 4 (April 28, 2023): Translational Lung Cancer Research

Editorial Commentary

Targeting the adenosine 2A receptor in non-small cell lung cancer: shooting with blank bullets?
Esther Garcia-Lorenzo, Victor Moreno
Translational Lung Cancer Research  
2023;
12
(4)
:653-656
.
 (28 April 2023) 
PDF Full Text (1147) COI Form Open Access Get Permission
DNA methylation profiling in early lung adenocarcinoma to predict response to immunotherapy
Charles De Smet
Translational Lung Cancer Research  
2023;
12
(4)
:657-660
.
 (28 April 2023) 
PDF Full Text (1266) COI Form Open Access Get Permission
New potential targeted strategies in small cell lung cancer
María de Toro, Cristina Pangua, Gloria Serrano-Montero, Miguel Ángel Lara, Jacobo Rogado
Translational Lung Cancer Research  
2023;
12
(4)
:661-664
.
 (28 April 2023) 
PDF Full Text (1101) COI Form Open Access Get Permission
Penetrating the central nervous system sanctuary of KRAS, a target once thought “undruggable”
Misako Nagasaka, Asfar S. Azmi
Translational Lung Cancer Research  
2023;
12
(4)
:665-668
.
 (28 April 2023) 
PDF Full Text (1171) COI Form Open Access Get Permission
Evaluating the intracranial activity of adagrasib
Rupesh Kotecha, Alonso La Rosa, Tugce Kutuk, Manmeet S. Ahluwalia, Minesh P. Mehta
Translational Lung Cancer Research  
2023;
12
(4)
:669-675
.
 (28 April 2023) 
PDF Full Text (1327) COI Form Open Access Get Permission

Original Article

False positivity in break apart fluorescence in-situ hybridization due to polyploidy
Anna Lena van Gulik, Ellen Sluydts, Liesbet Vervoort, Mark Kockx, Pim Kortman, Bauke Ylstra, Stephen P. Finn, Lukas Bubendorf, Idris Bahce, Daoud Sie, Teodora Radonic, Birgit Lissenberg-Witte, Erik Thunnissen
Translational Lung Cancer Research  
2023;
12
(4)
:676-688
.
 (28 April 2023) 
PDF Full Text (1971) Reporting Checklist Data Sharing Statement COI Form Open Access Get Permission
Efficacy of different therapies for brain metastases of non-small cell lung cancer: a systematic review and meta-analysis
Mo Chen, Lingyun Wei, Qin Wang, Jingyuan Xie, Ke Xu, Tangfeng Lv, Yong Song, Ping Zhan
Translational Lung Cancer Research  
2023;
12
(4)
:689-706
.
 (28 April 2023) 
PDF Full Text (2607) Reporting Checklist Peer Review File COI Form Open Access Get Permission
Genetic profile of thymic epithelial tumors in the Japanese population: an exploratory study examining potential therapeutic targets
Midori Shimada, Hirokazu Taniguchi, Hiroyuki Yamaguchi, Hiroshi Gyotoku, Daisuke Sasaki, Norihito Kaku, Chikako Senju, Hiroaki Senju, Erika Imamura, Shinnosuke Takemoto, Kazuko Yamamoto, Noriho Sakamoto, Yasushi Obase, Tomoshi Tsuchiya, Minoru Fukuda, Hiroshi Soda, Kazuto Ashizawa, Junya Fukuoka, Takeshi Nagayasu, Katsunori Yanagihara, Hiroshi Mukae
Translational Lung Cancer Research  
2023;
12
(4)
:707-718
.
 (28 April 2023) 
PDF Full Text (2259) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access Get Permission
Safety and feasibility of carboplatin and paclitaxel in combination with nintedanib for non-small cell lung cancer patients with idiopathic pulmonary fibrosis: a prospective pilot study
Tomonori Makiguchi, Hisashi Tanaka, Koichi Okudera, Kageaki Taima, Sadatomo Tasaka
Translational Lung Cancer Research  
2023;
12
(4)
:719-726
.
 (28 April 2023) 
PDF Full Text (1942) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access Get Permission
High expression of transcription factor POU2F1 confers improved survival on smokers with lung adenocarcinoma: a retrospective study of two cohorts
Arik Bernard Schulze, Daniela Vanessa Wenge, Georg Evers, Birthe Heitkötter, Annalen Bleckmann, Lars Henning Schmidt, Michael Mohr, Wolfgang Hartmann, Maria Francisca Arteaga, Jan-Henrik Mikesch
Translational Lung Cancer Research  
2023;
12
(4)
:727-741
.
 (28 April 2023) 
PDF Full Text (1948) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access Get Permission
Real world efficacy of osimertinib in second line/beyond in patients with metastatic EGFR+ non-small cell lung cancer and role of paired tumour-plasma T790M testing at tyrosine kinase inhibitor resistance
Jun Ma, Sze Huey Tan, Daniel Xing Cheng Yin, Nguyen Tuan Anh Tran, Gek San Tan, Gillianne Geet Yi Lai, Mei-Kim Ang, Ravindran Kanesvaran, Amit Jain, Tanujaa Rajasekaran, Eng-Huat Tan, Tony Kiat Hon Lim, Daniel Shao-Weng Tan, Darren Wan-Teck Lim, Quan Sing Ng, Wan Ling Tan
Translational Lung Cancer Research  
2023;
12
(4)
:742-753
.
 (28 April 2023) 
PDF Full Text (2113) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access Get Permission
Development of a cuproptosis-related signature for prognosis prediction in lung adenocarcinoma based on WGCNA
Xiaodong Ling, Luquan Zhang, Chengyuan Fang, Hao Liang, Jinhong Zhu, Jianqun Ma
Translational Lung Cancer Research  
2023;
12
(4)
:754-769
.
 (28 April 2023) 
PDF Full Text (2720) Reporting Checklist Peer Review File COI Form Open Access Get Permission
Circ_0087378 intensifies the malignant behavior of non-small cell lung cancer cells in vitro by facilitating DDR1 via sponging miR-199a-5p
Fei Ming, Binfeng Li, Shengzhong Yi, Guoliang Pi
Translational Lung Cancer Research  
2023;
12
(4)
:770-785
.
 (28 April 2023) 
PDF Full Text (1533) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access Get Permission
Real world experience with camrelizumab in patients with advanced non-small cell lung cancer: a prospective multicenter cohort study (NOAH-LC-101)
Rong Wang, Meiqi Shi, Mei Ji, Zhengxiang Han, Lingxiang Chen, Yong Liu, Kaihua Lu, Lianke Liu, Bi Chen, Xizhi Zhang, Liyun Miao, Yongqian Shu
Translational Lung Cancer Research  
2023;
12
(4)
:786-796
.
 (28 April 2023) 
PDF Full Text (1519) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access Get Permission
Immunotherapy for non-small cell lung cancer with EGFR or HER2 exon 20 insertion mutations: a real-world analysis
Mai Zhang, Qian Huang, Min Yu, Jianxin Xue, Meijuan Huang, You Lu, Yan Zhang
Translational Lung Cancer Research  
2023;
12
(4)
:797-807
.
 (28 April 2023) 
PDF Full Text (2845) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access Get Permission
Establishing a predictive model for tumor mutation burden status based on CT radiomics and clinical features of non-small cell lung cancer patients
Jihua Yang, Wenjia Shi, Zhen Yang, Hang Yu, Miaoyu Wang, Yuanhui Wei, Juyi Wen, Wei Zheng, Peng Zhang, Wei Zhao, Liang’an Chen
Translational Lung Cancer Research  
2023;
12
(4)
:808-823
.
 (28 April 2023) 
PDF Full Text (1904) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access Get Permission

Review Article

Adjuvant therapies in stages I–III epidermal growth factor receptor-mutated lung cancer: current and future perspectives
Mark G. Kris, Tetsuya Mitsudomi, Solange Peters
Translational Lung Cancer Research  
2023;
12
(4)
:824-836
.
 (28 April 2023) 
PDF Full Text (2989) Peer Review File COI Form Open Access Get Permission
Biology and impact of lineage plasticity in ALK-positive NSCLC: a narrative review
Catherine B. Meador, Zofia Piotrowska
Translational Lung Cancer Research  
2023;
12
(4)
:837-856
.
 (28 April 2023) 
PDF Full Text (2574) Reporting Checklist Peer Review File COI Form Open Access Get Permission
Current literature review on the tumor immune micro-environment, its heterogeneity and future perspectives in treatment of advanced non-small cell lung cancer
Jeong Uk Lim, Eunyoung Lee, Sang-Yun Lee, Hyeong Jun Cho, Dong Hyuck Ahn, Yongki Hwang, Joon Young Choi, Chang Dong Yeo, Chan Kwon Park, Seung Joon Kim
Translational Lung Cancer Research  
2023;
12
(4)
:857-876
.
 (28 April 2023) 
PDF Full Text (3177) Reporting Checklist Peer Review File COI Form Open Access Get Permission
Significance of circulating tumor cells in lung cancer: a narrative review
Gerhard Hamilton, Barbara Rath, Sandra Stickler
Translational Lung Cancer Research  
2023;
12
(4)
:877-894
.
 (28 April 2023) 
PDF Full Text (3036) Reporting Checklist Peer Review File COI Form Open Access Get Permission
Clinical characteristics and targeted therapy of different gene fusions in non-small cell lung cancer: a narrative review
Jiayan Chen, Chunwei Xu, Jiawen Lv, Wanjun Lu, Yixue Zhang, Dong Wang, Yong Song
Translational Lung Cancer Research  
2023;
12
(4)
:895-908
.
 (28 April 2023) 
PDF Full Text (3502) Reporting Checklist Peer Review File COI Form Open Access Get Permission
A narrative review from gut to lungs: non-small cell lung cancer and the gastrointestinal microbiome
Hely Shah, Terry L. Ng
Translational Lung Cancer Research  
2023;
12
(4)
:909-926
.
 (28 April 2023) 
PDF Full Text (2471) Reporting Checklist Peer Review File COI Form Open Access Get Permission

Case Report

Activity of osimertinib in a patient with stage IV non-small cell lung cancer harboring HER2 exon 19, p.L755P mutation: case report
Gudbjorg Jonsdottir, Mark Smith, Samuel Wood, Taher Abu Hejleh, Muhammad Furqan
Translational Lung Cancer Research  
2023;
12
(4)
:927-932
.
 (28 April 2023) 
PDF Full Text (2043) Reporting Checklist Peer Review File COI Form Open Access Get Permission
Case report: targeted sequencing improves the diagnosis of multiple synchronous lung cancers
Yufeng Ba, Haomiao Li, Jianping Zhu, Haoran Wang, Hongwei Lv, Chongqing Guo, Rui Sun, Jiawen Zheng, Lin Meng, Shanshan Shi
Translational Lung Cancer Research  
2023;
12
(4)
:933-939
.
 (28 April 2023) 
PDF Full Text (1584) Reporting Checklist Peer Review File COI Form Open Access Get Permission